Abstract:<p>One of the most prevalent forms of dementia is Alzheimer's disease (AD) which causes severe memory impairment within humans. As such, research into the early diagnosis of AD is essential to help treatment, which has led to significant advances in fluorescence imaging. Unfortunately, modern medicine and biology place increasingly strict requirements for fluorescent probes. Therefore, over recent years, researchers have taken strides to develop novel fluorescent molecular probes, with properties suitable for modern clinical applications, including low phototoxicity, weak background interference, deep tissue penetration, enhanced specificity, strong binding affinity, and suitable permeability through the blood–brain barrier (BBB). From these recent research results, many novel concepts for molecular design and fluorescence techniques have emerged. Herein, we present strategies towards the development of probes capable of meeting the advanced clinical requirements. As part of this review, we will summarize the characteristic enzymes and proteins involved in AD progression, including Amyloid-β, β-secretase, tau protein, monoamine oxidases, and methionine sulfoxide reductase. Then, we will evaluate some of the early probes and summarize the recent advancements made in the design of probes suitable for clinical applications, from which several strategies have emerged, such as increasing permeability to the blood–brain barrier, enhancing specificity by boosting binding affinity, and improving optical properties for <em>in vivo</em> imaging, etc. Then to conclude current strategies for early stage diagnosis of AD will be presented, and the opportunities as well as the remaining challenges will be outlined.</p>

Golgi-targeting viscosity probe for the diagnosis of Alzheimer's disease

Golgi-targeting Viscosity Probe for the Diagnosis of Alzheimer’s Disease

A Novel Viscosity Sensitive Hemicyanine Fluorescent Dye for Real-Time Imaging of Amyloid-Β Aggregation

Development of BODIPY-based fluorescent probes for imaging Aβ aggregates and lipid droplet viscosity

GFP-based Red-Emissive Fluorescent Probes for Dual Imaging of Β-Amyloid Plaques and Mitochondrial Viscosity.

Development of an AIE-active Fluorescent Probe for the Simultaneous Detection of Al3+ and Viscosity and Imaging in Alzheimer’s Disease Model

Development of an AIE-active fluorescent probe for the simultaneous detection of Al3+ and viscosity and imaging in Alzheimer's disease model

An Activatable Near-Infrared Fluorescent Probe for Methylglyoxal Imaging in Alzheimer's Disease Mice

A Probe for NIR-II Imaging and Multimodal Analysis of Early Alzheimer’s Disease by Targeting CTGF

High-fidelity imaging of amyloid-beta deposits with an ultrasensitive fluorescent probe facilitates the early diagnosis and treatment of Alzheimer's Disease

Rotor-Tuning Boron Dipyrromethenes for Dual-Functional Imaging of Aβ Oligomers and Viscosity

Development of Novel Near-Infrared GFP Chromophore-Based Fluorescent Probes for Imaging of Amyloid-Β Plaque and Viscosity

A probe for NIR-II imaging and multimodal analysis of early Alzheimer's disease by targeting CTGF

Research Progress Of Multi-Functional Fluorescent Probes For Alzheimer'S Disease Monitoring

Diagnosis of Alzheimer's Disease and in Situ Biological Imaging Via an Activatable Near-Infrared Fluorescence Probe.

Direct Quantification and Visualization of Homocysteine, Cysteine, and Glutathione in Alzheimer's and Parkinson's Disease Model Tissues

Current strategies for the development of fluorescence-based molecular probes for visualizing the enzymes and proteins associated with Alzheimer’s disease

A novel fluorescent protein chromophore analogue to simultaneously probe lysosome viscosity and -amyloid fibrils

A novel H2O2-activated NIR fluorescent probe for imaging β-amyloid fibrils and mitochondrial viscosity

Functional Insights from Targeted Imaging BACE1: the First Near-Infrared Fluorescent Probe for Alzheimer’s Disease Diagnosis

Light-controlled Fluorescent Probes for Precisely Monitoring Brain Amyloid-Β Aggregates in Alzheimer's Disease